ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,666Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 1499

$1.17M Total Retail Price of All Prescriptions

Rank: 46 out of 1499

533 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

33% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

30% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 7,186 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 872 394 S3 1 4
LISINOPRIL 397 201 2 1
LEVOTHYROXINE SODIUM 334 217 3 2
OMEPRAZOLE 295 151 4 5
FUROSEMIDE 265 162 5 7
RANITIDINE HCL 241 81 6 15
ZOLPIDEM TARTRATE 237 95 7 23
GABAPENTIN 237 123 7 13
SIMVASTATIN 235 123 9 3
MORPHINE SULFATE ER 233 50 S2 10 85
ATORVASTATIN CALCIUM 229 141 11 17
AMLODIPINE BESYLATE 210 136 12 6
TAMSULOSIN HCL 206 93 13 29
FENTANYL 190 77 S2 14 60
TRAZODONE HCL 190 65 14 32
CRESTOR 187 74 16 34
METFORMIN HCL 182 124 17 8
METHADONE HCL 180 44 S2 18 170
LISINOPRIL-HYDROCHLOROTHIAZIDE 178 130 19 25
OXYCONTIN 176 39 S2 20 99
HYDROCHLOROTHIAZIDE 173 93 21 9
CYMBALTA 168 64 22 40
LOVASTATIN 158 102 23 19
PRAVASTATIN SODIUM 156 113 24 18
METOPROLOL TARTRATE 150 105 25 10
OXYCODONE HCL-ACETAMINOPHEN 141 26 S2 26 81
CARVEDILOL 140 104 27 22
OXYCODONE HCL 137 37 S2 28 79
CYCLOBENZAPRINE HCL 132 34 R 29 41
NAPROXEN 131 52 30 63
NEXIUM 124 54 31 28
SPIRIVA 121 37 32 44
WARFARIN SODIUM 115 82 33 12
CARISOPRODOL 110 37 R 34 71
TRAMADOL HCL 109 80 35 16
POTASSIUM CHLORIDE 108 75 36 11
CELEBREX 106 76 37 77
MELOXICAM 105 81 38 27
IBUPROFEN 98 31 39 70
PROAIR HFA 98 44 39 30
OXYCODONE-ACETAMINOPHEN 95 51 S2 41 80
ROPINIROLE HCL 93 44 42 55
METOPROLOL SUCCINATE 93 64 42 20
CITALOPRAM HBR 93 66 42 14
ISOSORBIDE MONONITRATE ER 92 77 45 51
LYRICA 88 12 46 90
AMITRIPTYLINE HCL 83 37 R 47 49
LIPITOR 82 39 48 107
FLUTICASONE PROPIONATE 82 54 48 31
ALENDRONATE SODIUM 80 65 50 33
VYTORIN 79 40 51 154
FLUOXETINE HCL 78 44 52 43
ATENOLOL 78 18 52 21
PROMETHAZINE HCL 75 12 R 54 138
ENDOCET 73 14 S2 55 111
EXALGO 72 13 S2 56 290
METOCLOPRAMIDE HCL 70 14 57 114
MIRTAZAPINE 67 51 58 50
ADVAIR DISKUS 65 17 59 37
TOPIRAMATE 63 23 60 128
AMLODIPINE BESYLATE-BENAZEPRIL 62 43 61 109
OXYBUTYNIN CHLORIDE 60 59 62 95
FENOFIBRATE 59 46 63 66
DONEPEZIL HCL 59 51 63 35
LANTUS SOLOSTAR 58 14 65 89
TRICOR 57 11 66 103
TRILIPIX 57 27 66 171
PRAMIPEXOLE DIHYDROCHLORIDE 57 17 66 179
GLYBURIDE 57 26 R 66 69
HYDROMORPHONE HCL 56 0 S2 70 189
TIZANIDINE HCL 56 0 70 105
TEKTURNA 56 31 70 269
MORPHINE SULFATE 55 0 S2 73 205
PEN NEEDLE 55 0 73 120
SINGULAIR 55 16 73 67
CLONIDINE HCL 54 32 76 57
GLYBURIDE-METFORMIN HCL 53 52 R 77 165
ZETIA 52 36 78 91
DEXILANT 51 25 79 225
VESICARE 51 39 79 180
TESTOSTERONE CYPIONATE 51 11 S3 79 281
LOVAZA 51 26 79 136
TRIAMCINOLONE ACETONIDE 50 28 83 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.